Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold - PubMed (original) (raw)

Multicenter Study

Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold

N Chaturvedi et al. Kidney Int. 2001 Jul.

Free article

Abstract

Background: The occurrence of microalbuminuria in type 1 diabetes is strongly predictive of renal and cardiovascular disease and is still likely to occur despite improvements in glycemic control. A better understanding of microalbuminuria is required to inform new interventions. We determined the incidence and risk factors for microalbuminuria [albumin excretion rate (AER) 20 to 200 microg/min] in the EURODIAB Prospective Complications Study.

Methods: This is a seven-year follow-up (between 1988 and 1991) of 1134 normoalbuminuric men and women (aged 15 to 60) with type 1 diabetes from 31 European centers. Risk factors and AER were measured centrally.

Results: The incidence of microalbuminuria was 12.6% over 7.3 years. Independent baseline risk factors were HbA1c (7.1 vs. 6.2%, P = 0.0001) and AER (9.6 vs. 7.8 microg/min, P = 0.0001) and, independent of these, fasting triglyceride (0.99 vs. 0.88 mmol/L, P = 0.01), low-density lipoprotein cholesterol (3.5 vs. 3.2 mmol/L, P = 0.02), body mass index (24.0 vs. 23.4 kg/m2, P = 0.01), and waist to hip ratio (WHR; 0.85 vs. 0.83, P = 0.009). Triglyceride and WHR risk factors were nearly as strong as AER in predicting microalbuminuria (standardized regression effects of 1.3 for triglyceride and WHR and 1.5 for AER). Blood pressure at follow-up, but not at baseline, was also raised in those who progressed. There was no evidence of a threshold of HbA1c on microalbuminuria risk.

Conclusions: The incidence of microalbuminuria in patients with type 1 diabetes remains high, and there is no apparent glycemic threshold for it. Markers of insulin resistance, such as triglyceride and WHR, are strong risk factors. Systemic blood pressure is not raised prior to the onset of microalbuminuria.

PubMed Disclaimer

Cited by

A Narrative Review of Retinopathy in Diabetic Patients.
Gupta S, Thool AR. Gupta S, et al. Cureus. 2024 Jan 15;16(1):e52308. doi: 10.7759/cureus.52308. eCollection 2024 Jan. Cureus. 2024. PMID: 38357071 Free PMC article. Review.
Estimated glucose disposal rate is associated with retinopathy and kidney disease in young people with type 1 diabetes: a nationwide observational study.
Linn W, Persson M, Rathsman B, Ludvigsson J, Lind M, Andersson Franko M, Nyström T. Linn W, et al. Cardiovasc Diabetol. 2023 Mar 19;22(1):61. doi: 10.1186/s12933-023-01791-x. Cardiovasc Diabetol. 2023. PMID: 36935526 Free PMC article.
Reduced methylation correlates with diabetic nephropathy risk in type 1 diabetes.
Khurana I, Kaipananickal H, Maxwell S, Birkelund S, Syreeni A, Forsblom C, Okabe J, Ziemann M, Kaspi A, Rafehi H, Jørgensen A, Al-Hasani K, Thomas MC, Jiang G, Luk AO, Lee HM, Huang Y, Thewjitcharoen Y, Nakasatien S, Himathongkam T, Fogarty C, Njeim R, Eid A, Hansen TW, Tofte N, Ottesen EC, Ma RC, Chan JC, Cooper ME, Rossing P, Groop PH, El-Osta A. Khurana I, et al. J Clin Invest. 2023 Feb 15;133(4):e160959. doi: 10.1172/JCI160959. J Clin Invest. 2023. PMID: 36633903 Free PMC article.
The Prevalence of Chronic Kidney Disease and Albuminuria in Patients With Type 1 and Type 2 Diabetes Attending a Single Centre.
Majeed MS, Ahmed F, Teeling M. Majeed MS, et al. Cureus. 2022 Dec 6;14(12):e32248. doi: 10.7759/cureus.32248. eCollection 2022 Dec. Cureus. 2022. PMID: 36620790 Free PMC article.
Plasma levels of tissue inhibitor of metalloproteinase-1 in patients with type 1 diabetes mellitus associate with early diabetic neuropathy and nephropathy.
Papadopoulou-Marketou N, Whiss PA, Eriksson AC, Hyllienmark L, Papassotiriou I, Wahlberg J. Papadopoulou-Marketou N, et al. Diab Vasc Dis Res. 2021 Mar-Apr;18(2):14791641211002470. doi: 10.1177/14791641211002470. Diab Vasc Dis Res. 2021. PMID: 33775157 Free PMC article.

Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold - PubMed (original) (raw)